First-line crizotinib in ALK-positive lung cancer
- PMID: 25693023
- DOI: 10.1056/NEJMc1415973
First-line crizotinib in ALK-positive lung cancer
Erratum in
- N Engl J Med. 2015 Feb 26;372(9):887
Comment in
-
First-line crizotinib in ALK-positive lung cancer.N Engl J Med. 2015 Feb 19;372(8):782. doi: 10.1056/NEJMc1415973. N Engl J Med. 2015. PMID: 25693021 No abstract available.
Comment on
-
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440. N Engl J Med. 2014. PMID: 25470694 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical